| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Product containing precisely potassium chloride 1.5 gram/1 sachet powder for conventional release oral solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
| Potassium chloride 750 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
| Potassium chloride 1g/5mL solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
| Potassium chloride 1g/mL solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
| Potassium chloride 10 meq750 mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
| Potassium chloride 8meq |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
| Potassium chloride 20% solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
| Potassium chloride 20meq/10mL injection solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
| Potassium chloride 1.5g |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
| Product containing potassium chloride 10 mEq/1 each oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
| Product containing precisely potassium chloride 1.5 gram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
| Potassium chloride 20meq/pkt solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
| Potassium chloride 750mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
| Product containing potassium chloride 20 mEq/1 each oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
| Potassium chloride 20meq/15mL solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
| Potassium chloride 10% |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
| Potassium chloride 600mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
| Potassium chloride 600 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
| Product containing precisely potassium chloride 750 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
| Potassium chloride 20meq powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
| Potassium chloride 1.5g/unt powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
| Product containing precisely potassium chloride 1.875 gram/1 sachet powder for conventional release oral solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
| Product containing potassium chloride (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
| Product containing glucose and potassium chloride and sodium chloride (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
| Dextrose + potassium chloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
| Product containing potassium chloride and sodium chloride (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
| Product containing furosemide and potassium chloride (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
| Product containing glucose and potassium chloride (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
| Product containing potassium perchlorate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
| Product containing potassium chloride and sodium chloride and sodium lactate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
| Potassium chloride injection solution ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
| Product containing bisacodyl and macrogol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
| Measurement of urea, sodium, potassium, chloride, bicarbonate and creatinine (procedure) |
Component |
False |
Potassium |
Inferred relationship |
Some |
6 |
| Measurement of urea, sodium, potassium, chloride, bicarbonate and glucose (procedure) |
Component |
False |
Potassium |
Inferred relationship |
Some |
6 |
| allergie au potassium |
Causative agent (attribute) |
False |
Potassium |
Inferred relationship |
Some |
1 |
| Parenteral potassium allergy |
Causative agent (attribute) |
False |
Potassium |
Inferred relationship |
Some |
1 |
| Oral potassium allergy |
Causative agent (attribute) |
False |
Potassium |
Inferred relationship |
Some |
1 |
| Increase or decrease in potassium content of the diet. |
Direct substance |
True |
Potassium |
Inferred relationship |
Some |
1 |
| Increase in potassium content of diet compared to the assessed baseline intake of potassium for the individual. |
Direct substance |
False |
Potassium |
Inferred relationship |
Some |
2 |
| Decrease in potassium content of the diet compared to the assessed baseline intake of potassium for the individual. |
Direct substance |
False |
Potassium |
Inferred relationship |
Some |
2 |
| Providing potassium based on suboptimal food or fluid intake, iatrogenic deficiency or medical diagnosis. |
Direct substance |
False |
Potassium |
Inferred relationship |
Some |
1 |
| Product containing potassium in ophthalmic dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
| Potassium citrate (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
False |
Potassium |
Inferred relationship |
Some |
|
| Frusemide+potassium 40mg/8Mmol prolonged-release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
| Frusemide+potassium 20mg/10Mmol prolonged-release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
| Potassium carbonate |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
False |
Potassium |
Inferred relationship |
Some |
|
| Potassium glycerophosphate trihydrate (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
False |
Potassium |
Inferred relationship |
Some |
|
| Potassium glycerophosphate anhydrous |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
False |
Potassium |
Inferred relationship |
Some |
|
| Product containing potassium in oropharyngeal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
1 |
| Product containing potassium (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Potassium |
Inferred relationship |
Some |
1 |
| Potassium chloride 600 mg prolonged-release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
| Potassium chloride 1.5 g prolonged-release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
| Potassium chloride 10meq prolonged-release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
| Product containing precisely potassium chloride 750 milligram/1 each prolonged-release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
| Product containing potassium in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Potassium |
Inferred relationship |
Some |
1 |
| Product containing potassium in ocular dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Potassium |
Inferred relationship |
Some |
1 |
| Bumetanide and potassium only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Potassium |
Inferred relationship |
Some |
2 |
| Bendroflumethiazide and potassium only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Potassium |
Inferred relationship |
Some |
2 |
| Product containing only furosemide and potassium (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Potassium |
Inferred relationship |
Some |
2 |
| Product containing only potassium (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Potassium |
Inferred relationship |
Some |
1 |
| Product containing only potassium in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Potassium |
Inferred relationship |
Some |
1 |
| Potassium only product in ocular dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Potassium |
Inferred relationship |
Some |
1 |
| Potassium only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Potassium |
Inferred relationship |
Some |
1 |
| Product containing only potassium in oromucosal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Potassium |
Inferred relationship |
Some |
1 |
| Product containing only potassium in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Potassium |
Inferred relationship |
Some |
1 |
| Propensity to adverse reaction to potassium (finding) |
Causative agent (attribute) |
True |
Potassium |
Inferred relationship |
Some |
1 |
| Potassium intake |
This attribute specifies the resulting output of the process characterized by the observed feature. |
False |
Potassium |
Inferred relationship |
Some |
2 |
| Estimated quantity of intake of potassium in 24 hours |
This attribute specifies the resulting output of the process characterized by the observed feature. |
False |
Potassium |
Inferred relationship |
Some |
6 |
| Decrease in potassium content of the diet compared to the assessed baseline intake of potassium for the individual. |
Direct substance |
True |
Potassium |
Inferred relationship |
Some |
1 |
| Increase in potassium content of diet compared to the assessed baseline intake of potassium for the individual. |
Direct substance |
True |
Potassium |
Inferred relationship |
Some |
1 |
| Product containing potassium in oromucosal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Potassium |
Inferred relationship |
Some |
1 |
| The known quantity of intake of potassium from all sources including food, beverages, breastmilk/formula, supplements, and via enteral and parenteral routes. |
This attribute specifies the resulting output of the process characterized by the observed feature. |
False |
Potassium |
Inferred relationship |
Some |
5 |
| Potassium poisoning |
Causative agent (attribute) |
True |
Potassium |
Inferred relationship |
Some |
1 |
| Estimated quantity of potassium needed for nutritional adequacy in one day. |
This attribute specifies the resulting output of the process characterized by the observed feature. |
False |
Potassium |
Inferred relationship |
Some |
4 |
| Estimated quantity of intake of potassium in 24 hours |
This attribute specifies an entity that the process which the property characterizes specifically acts on. |
False |
Potassium |
Inferred relationship |
Some |
3 |
| The known quantity of intake of potassium from all sources including food, beverages, breastmilk/formula, supplements, and via enteral and parenteral routes. |
This attribute specifies an entity that the process which the property characterizes specifically acts on. |
False |
Potassium |
Inferred relationship |
Some |
5 |
| Potassium intake |
This attribute specifies an entity that the process which the property characterizes specifically acts on. |
False |
Potassium |
Inferred relationship |
Some |
2 |
| Estimated quantity of potassium needed for nutritional adequacy in one day. |
This attribute specifies an entity that the process which the property characterizes specifically acts on. |
False |
Potassium |
Inferred relationship |
Some |
4 |
| Estimated quantity of potassium needed for nutritional adequacy in one day. |
This attribute specifies an entity that the process which the property characterizes specifically acts on. |
True |
Potassium |
Inferred relationship |
Some |
1 |
| Estimated quantity of intake of potassium in 24 hours |
This attribute specifies an entity that the process which the property characterizes specifically acts on. |
True |
Potassium |
Inferred relationship |
Some |
1 |
| The known quantity of intake of potassium from all sources including food, beverages, breastmilk/formula, supplements, and via enteral and parenteral routes. |
This attribute specifies an entity that the process which the property characterizes specifically acts on. |
True |
Potassium |
Inferred relationship |
Some |
1 |
| Potassium intake |
This attribute specifies an entity that the process which the property characterizes specifically acts on. |
True |
Potassium |
Inferred relationship |
Some |
1 |
| 24 hour urine potassium output measurement |
Component |
True |
Potassium |
Inferred relationship |
Some |
1 |
| Cerebrospinal fluid potassium measurement (procedure) |
Component |
True |
Potassium |
Inferred relationship |
Some |
1 |
| Dialysis fluid potassium measurement (procedure) |
Component |
True |
Potassium |
Inferred relationship |
Some |
1 |
| Blood potassium measurement |
Component |
True |
Potassium |
Inferred relationship |
Some |
1 |
| Fluid sample potassium measurement |
Component |
True |
Potassium |
Inferred relationship |
Some |
1 |
| Sweat potassium measurement |
Component |
True |
Potassium |
Inferred relationship |
Some |
1 |
| Serum potassium measurement |
Component |
True |
Potassium |
Inferred relationship |
Some |
1 |
| Measurement of urea, sodium, potassium, chloride, bicarbonate and glucose (procedure) |
Component |
True |
Potassium |
Inferred relationship |
Some |
1 |
| Measurement of urea, sodium, potassium, chloride, bicarbonate and creatinine (procedure) |
Component |
True |
Potassium |
Inferred relationship |
Some |
1 |
| Potassium/sodium ratio measurement |
Component |
True |
Potassium |
Inferred relationship |
Some |
1 |
| Potassium measurement, urine |
Component |
True |
Potassium |
Inferred relationship |
Some |
1 |
| Plasma potassium level (procedure) |
Component |
True |
Potassium |
Inferred relationship |
Some |
1 |
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]